Treatment with darovasertib resulted in robust ocular tumor shrinkage, lower simulated radiation doses to the eye and meaningful visual gains and reduced long-term risk of blindness for patients in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback